Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | CD24Fc |
| Synonyms | |
| Therapy Description |
CD24Fc is a fusion protein that consists of human IgG1-Fc domain fused to the extracellular domain of CD24, which binds to and increases Siglec-G signaling, potentially resulting in improved anti-tumor immune response (PMID: 28724800). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| CD24Fc | CD24Fc is a fusion protein that consists of human IgG1-Fc domain fused to the extracellular domain of CD24, which binds to and increases Siglec-G signaling, potentially resulting in improved anti-tumor immune response (PMID: 28724800). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|